Robot‐assisted radical prostatectomy feasibility and setting with the <scp>Hugo</scp>™ robot‐assisted surgery system

Sarchi, Luca; Mottaran, Angelo; Bravi, Carlo Andrea; Paciotti, Marco; Farinha, Rui; Piazza, Pietro; Puliatti, Stefano; Groote, Ruben De; Naeyer, Geert De; Gallagher, Anthony G.; Breda, Alberto; Mottrie, Alexandre

doi:10.1111/bju.15819

Cited by 54 publications

(32 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A standard configuration was used to place the trocars and set the system. This configuration was first developed at the ORSI Academy and tested in a cadaver laboratory, and only then implemented in clinical practice [1,2]. It guarantees enough space for the bed-side assistant and scrub nurse, and it allows the avoidance of clashing between the robotic arms.…”

Section: Discussionmentioning

confidence: 99%

Nerve‐sparing robot‐assisted radical prostatectomy with the HUGO™ robot‐assisted surgery system using the ‘Aalst technique’

Paciotti,

Bravi,

Mottaran

et al. 2023

BJU International

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Nerve‐sparing robot‐assisted radical prostatectomy with the HUGO™ robot‐assisted surgery system using the ‘Aalst technique’

Paciotti,

Bravi,

Mottaran

et al. 2023

BJU International

Self Cite

View full text Add to dashboard Cite

“…Still, besides these clinical factors, there are also concerns about the costs of robotic surgery that have often contained its broad adoption. In this regard, the introduction of novel robotic platforms [21] , [22] , [23] may mitigate this limitation, expanding the availability of robotic surgery. Finally, another factor that might favor the transition to robotic surgery is recent evidence on robot-assisted radical prostatectomy showing that robotic surgery might have the potential to flatten the learning curve, allowing surgeons to reach adequate outcome in an early phase of their career [12] , [24] .…”

Section: Discussionmentioning

confidence: 99%

The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing Surgery

Bravi

Rosiello

Mazzone

et al. 2023

European Urology Open Science

Self Cite

View full text Add to dashboard Cite

“…This evolution forced Intuitive to present new technical solutions and favored the development of other surgical robotic compa-nies that delivered novel systems to tackle Da Vinci's drawbacks in its maneuverability inside the OR and inside the patient. One of the newest potential contenders is Hugo™ RAS (Medtronic, Minneapolis, MN, USA), a multi-incision modular platform, that only has very few publications in the field of Urology [91][92][93].…”

Section: Discussionmentioning

confidence: 99%

New Robotic Platforms for Gynecology. Are We Achieving One of the Golden Goals?

Farinha¹,

Sarchi²,

Paciotti³

et al. 2022

Clin. Exp. Obstet. Gynecol.

View full text Add to dashboard Cite

Objective: To summarize the scientific published literature on new robotic platforms with potential use in gynecology and review their evolution from inception until the present day. The goal was to describe the current characteristics and possible prospects of these platforms. Mechanism: A non-systematic search of PubMed, Cochrane Library Central, EMBASE, MEDLINE, and Scopus databases was conducted to identify scientific literature on new robotic platforms and review their evolution from inception until January 2022. Only English-language publications were included in this analysis. The following keywords were used: "new robotic platforms", "robot", "Revo-I", "Versius®", "Senhance®", "Single-Site", "Single-Port", "Multi-Port", "EDGE SP1000", "Flex®", and "Hominis®". Abstract reviews were conducted to determine the relevance of the review aims. Full-text analysis of all relevant English-language original articles was subsequently performed by one author (R.F.) and summarized after discussion with an independent third party (L.S., M.P.). No formal quality assessment of the included studies was conducted. Findings in brief: The Da Vinci robotic system is the leading platform in the robotic surgery market. Other new platforms have published peer-reviewed articles in the field of gynecology. Senhance® and Da Vinci SP® have the most substantial proof of their capacity to perform multi-incision and single-incision robotic surgery, respectively. Hominis® has the potential to play a major role in ultra-minimally invasive and scarless approaches. Conclusions: The significant advantages of Intuitive's robots justify their worldwide dissemination. However, their drawbacks have motivated other companies to develop innovative solutions. Our research shows that the majority of these new platforms are still at the beginning of their technical and scientific validation but seem very promising.

show abstract

Robot‐assisted radical prostatectomy feasibility and setting with the Hugo™ robot‐assisted surgery system

Cited by 54 publications

References 8 publications

Nerve‐sparing robot‐assisted radical prostatectomy with the HUGO™ robot‐assisted surgery system using the ‘Aalst technique’

Nerve‐sparing robot‐assisted radical prostatectomy with the HUGO™ robot‐assisted surgery system using the ‘Aalst technique’

The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing Surgery

New Robotic Platforms for Gynecology. Are We Achieving One of the Golden Goals?

Contact Info

Product

Resources

About